Leishmaniasis
Leishmaniasis infection
A disease caused by any of a number of species of protozoa in the genus leishmania. There are four major clinical types of this infection: cutaneous old and new world) leishmaniasis, cutaneous), diffuse cutaneous leishmaniasis, diffuse cutaneous), mucocutaneous leishmaniasis, mucocutaneous), and visceral leishmaniasis, visceral).
A parasitic infection caused by protozoa of the genus leishmania. It is transmitted to humans via the bite of sandflies. There are three main forms of the disease: cutaneous, mucocutaneous, and visceral leishmaniasis. Cutaneous leishmaniasis causes skin ulcers; mucocutaneous leishmaniasis causes destructive lesions of the mucous membranes of the nose, mouth, and throat; visceral leishmaniasis is the most severe form of the disease and is manifested with anemia, weight loss, hepatomegaly and splenomegaly.
Disease caused by any of a number of species of protozoa in the genus leishmania; there are four major clinical types of this infection: cutaneous old and new world), diffuse cutaneous, mucocutaneous, and visceral; visceral is characterized by fever, chills, vomiting, anemia, hepatosplenomegaly, leukopenia, hypergammaglobulinemia, emaciation, and an earth-gray color of the skin; cutaneous is characterized by development of single or multiple localized lesions on exposed areas of skin that typically ulcerate.
B55.9 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
The 2023 edition of ICD-10-CM B55.9 became effective on October 1, 2022.
This is the American ICD-10-CM version of B55.9 – other international versions of ICD-10 B55.9 may differ.